Most Active Healthtech Investors in San Francisco 2026

15 firms writing Healthtech checks in San Francisco, led by Correlation Ventures, Elefund, Esplanade Ventures — ranked by verified deal count.

Healthtech in San Francisco accounts for 41 tracked companies with verified cap-table data, 41 of which disclose round sizes totalling $7.9B. The median disclosed raise is $120M, and the largest is Carbon Health at $983M, ahead of Innovaccer ($675M) and Alto Pharmacy ($600M).

The names that recur most often on these healthtech cap tables are Khosla Ventures (4 companies), General Catalyst (4 companies), Andreessen Horowitz (4 companies), Index Ventures (4 companies), 8VC (4 companies), Founders Fund (3 companies). By latest disclosed round, the market skews Series C (12), Series B (10), Series A (6), Seed (3).

Best funded Healthtech in San Francisco companies

  1. Carbon Health — $983M (latest: Series D)
  2. Innovaccer — $675M (latest: Series F)
  3. Alto Pharmacy — $600M (latest: Series F)
  4. Forward — $600M (latest: Series E)
  5. Tonal — $580M (latest: Series E)
  6. Ambience Healthcare — $343M (latest: Series C)
  7. Truepill — $256M (latest: Series D)
  8. Foodsmart — $247M (latest: Growth)
  9. PayZen — $240M
  10. Assort Health — $222M (latest: Series C)
  11. Angle Health — $200M (latest: Series B)
  12. Hims & Hers — $200M (latest: Seed)
  13. Omada Health — $192M (latest: IPO)
  14. Strava — $180M (latest: Growth)
  15. NexHealth — $177M (latest: Series C)

Sector × city funding reports (20)

All research · Investor directory · Company funding database · Fundraising library